Merida Capital Launches Third Fund Targeting Cannabis Space
Mitch Baruchowitz’s Merida continues to build positions in the cannabis space. The firm just launched its third fund that will look to invest $200m across the entire cannabis ecosystem. The PE firm is only two years old, but has already invested in several dozens players in the space.
Background: Chronic itch with secondary scratch lesions such as prurigo has a major impact on quality of life. Management: Avoid use of corticosteroids as premedication or at any time during treatment with tisagenlecleucel, except in the case of life-threatening emergency (such as resistant cytokine release syndrome). In nonclinical studies vortioxetine related material was excreted in the milk of lactating rats www.farmaciasonline.org. We strongly encourage you to talk with your health care professional about your specific medical condition and treatments.
Merida also announced the opening of an office in Toronto, Canada to look at deals in a country where cannabis is entirely legal.
